190
Views
17
CrossRef citations to date
0
Altmetric
Articles

Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis

, , , , , , , , & show all
Pages 284-287 | Accepted 16 Feb 2015, Published online: 14 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, Laura Bazzichi, Manuela Di Franco, Fausto Salaffi, Daniela Marotto, Angela Ceribelli, Jacob N Ablin & Winfred Hauser. (2019) Medical cannabis and cannabinoids in rheumatology: where are we now?. Expert Review of Clinical Immunology 15:10, pages 1019-1032.
Read now
Barbara L. F. Kaplan. (2018) Endocannabinoid engagement of CB2 regulates RSV-induced immunity. Virulence 9:1, pages 494-495.
Read now

Articles from other publishers (15)

Victoria P. Werth, Emily Hejazi, Sandra M. Pena, Jessica Haber, Majid Zeidi, Nithin Reddy, Joyce Okawa, Rui Feng, Muhammad M. Bashir, Kirubel Gebre, Arvin S. Jadoo, Josef Symon S. Concha, Nancy Dgetluck, Scott Constantine & Barbara White. (2022) Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial. Journal of Investigative Dermatology 142:10, pages 2651-2659.e1.
Crossref
Qing-Rong Liu, Kanikkai Raja Aseer, Qin Yao, Xiaoming Zhong, Paritosh Ghosh, Jennifer F. O’Connell & Josephine M. Egan. (2022) Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes. Frontiers in Pharmacology 12.
Crossref
Mostafa Rastegar, Saeed Samadizadeh, Mohammad Yasaghi, Abdolvahab Moradi, Alijan Tabarraei, Vahid Salimi & Alireza Tahamtan. (2021) Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking. Archives of Virology 166:11, pages 3117-3126.
Crossref
Gábor Turu, Eszter Soltész-Katona, András Dávid Tóth, Cintia Juhász, Miklós Cserző, Ádám Misák, András Balla, Marc G. Caron & László Hunyady. (2021) Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor. Frontiers in Endocrinology 12.
Crossref
Marta Bryk & Katarzyna Starowicz. (2021) Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. Pharmacological Reports 73:3, pages 681-699.
Crossref
Norbert E. Kaminski & Barbara L.F. Kaplan. 2021. Advances in Immunopharmacology. Advances in Immunopharmacology 1 59 .
Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola & Francesca Punzo. (2020) Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?. International Journal of Molecular Sciences 21:11, pages 3809.
Crossref
Alireza Tahamtan, Shahrzad Rezaiy, Saeed Samadizadeh, Abdolvahab Moradi, Alijan Tabarraei, Naeme Javid, Morteza Oladnabi & Mohammad Hosein Naeimi. (2019) Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects. Journal of Molecular Neuroscience 70:1, pages 26-31.
Crossref
Maura Argenziano, Chiara Tortora, Giulia Bellini, Alessandra Di Paola, Francesca Punzo & Francesca Rossi. (2019) The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. International Journal of Molecular Sciences 20:23, pages 5875.
Crossref
Elaine D. Gonçalves & Rafael C. Dutra. (2019) Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?. Drug Discovery Today 24:9, pages 1845-1853.
Crossref
Morouj Ismail & Ghada Khawaja. (2018) Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis. Clinical Rheumatology 37:11, pages 2933-2938.
Crossref
Daphna Katz-Talmor, Itay Katz, Bat-Sheva Porat-Katz & Yehuda Shoenfeld. (2018) Cannabinoids for the treatment of rheumatic diseases — where do we stand?. Nature Reviews Rheumatology 14:8, pages 488-498.
Crossref
Jingru WangJuehua XuJie LiuHuang ZhuYanyan PengZhi-Ming DingHaiqing Hua. (2018) Genetic Variant Q63R of Cannabinoid Receptor 2 Causes Differential ERK Phosphorylation in Human Immune Cells. Genetic Testing and Molecular Biomarkers 22:5, pages 320-326.
Crossref
B.L.F. Kaplan. 2018. Comprehensive Toxicology. Comprehensive Toxicology 791 825 .
Julia M. Hillger, Beau le Roy, Zi Wang, Thea Mulder-Krieger, Dorret I. Boomsma, P. Eline Slagboom, Erik H.J. Danen, Adriaan P. IJzerman & Laura H. Heitman. (2017) Phenotypic screening of cannabinoid receptor 2 ligands shows different sensitivity to genotype. Biochemical Pharmacology 130, pages 60-70.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.